128 related articles for article (PubMed ID: 2776842)
1. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
[TBL] [Abstract][Full Text] [Related]
2. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A
Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
[TBL] [Abstract][Full Text] [Related]
3. Effect of nifedipine on neuropeptide Y-induced coronary vasoconstriction in anesthetized dogs.
Hayashi M; Aizawa Y; Satoh M; Suzuki K; Shibata A
Jpn Heart J; 1986 Mar; 27(2):251-7. PubMed ID: 3755186
[TBL] [Abstract][Full Text] [Related]
4. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
Tanaka E; Mori H; Chujo M; Yamakawa A; Mohammed MU; Shinozaki Y; Tobita K; Sekka T; Ito K; Nakazawa H
J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y is a vasoconstrictor of human coronary arteries.
Tseng CJ; Robertson D; Light RT; Atkinson JR; Robertson RM
Am J Med Sci; 1988 Jul; 296(1):11-6. PubMed ID: 3407677
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.
Maturi MF; Greene R; Speir E; Burrus C; Dorsey LM; Markle DR; Maxwell M; Schmidt W; Goldstein SR; Patterson RE
J Clin Invest; 1989 Apr; 83(4):1217-24. PubMed ID: 2703530
[TBL] [Abstract][Full Text] [Related]
7. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
Prieto D; Simonsen U; Nyborg NC
Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
[TBL] [Abstract][Full Text] [Related]
8. Adenosine receptor blockade with 8-p-sulfophenyltheophylline aggravates coronary constriction.
Martin SE; Tidmore WC; Patterson RE
Am J Physiol; 1991 Jun; 260(6 Pt 2):H1753-9. PubMed ID: 2058714
[TBL] [Abstract][Full Text] [Related]
9. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina.
Rosano GMC; Tousoulis D; McFadden E; Clarke J; Davies GJ; Kaski JC
Int J Cardiol; 2017 Jul; 238():123-127. PubMed ID: 28476516
[TBL] [Abstract][Full Text] [Related]
10. Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery.
Aizawa Y; Murata M; Hayashi M; Funazaki T; Ito S; Shibata A
Jpn Circ J; 1985 Jun; 49(6):584-8. PubMed ID: 3839860
[TBL] [Abstract][Full Text] [Related]
11. Effects of neuropeptide Y on double-peaked constrictor responses to periarterial nerve stimulation in isolated, perfused canine splenic arteries.
Yang XP; Chiba S
Jpn J Pharmacol; 2000 Jan; 82(1):67-70. PubMed ID: 10874591
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries.
Han C; Abel PW
J Cardiovasc Pharmacol; 1987 Jun; 9(6):675-81. PubMed ID: 2442533
[TBL] [Abstract][Full Text] [Related]
13. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs.
Otani N; Yang T; Levy MN
Circ Res; 1993 Apr; 72(4):816-26. PubMed ID: 8443869
[TBL] [Abstract][Full Text] [Related]
14. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
Hieble JP; Duesler JG; Daly RN
J Pharmacol Exp Ther; 1989 Aug; 250(2):523-8. PubMed ID: 2668503
[TBL] [Abstract][Full Text] [Related]
15. Coronary constriction due to neuropeptide Y: alleviation with cyclooxygenase blockers.
Martin SE; Patterson RE
Am J Physiol; 1989 Sep; 257(3 Pt 2):H927-34. PubMed ID: 2506768
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y potentiates contractile response to norepinephrine in skate coronary artery.
Bjenning C; Holmgren S; Farrell AP
Am J Physiol; 1993 Aug; 265(2 Pt 2):H661-5. PubMed ID: 8368368
[TBL] [Abstract][Full Text] [Related]
17. Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries: modulatory action of the endothelium.
Prieto D; Benedito S; Simonsen U; Nyborg NC
Br J Pharmacol; 1991 Mar; 102(3):754-8. PubMed ID: 1364848
[TBL] [Abstract][Full Text] [Related]
18. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
19. Effect of neuropeptide Y on isolated rat hearts.
Jolly SR; Ordoukhani A; Movahed A
Pharmacology; 1991; 43(3):121-7. PubMed ID: 1775516
[TBL] [Abstract][Full Text] [Related]
20. Adrenergic coronary tone during submaximal exercise in the dog is produced by circulating catecholamines. Evidence for adrenergic denervation supersensitivity in the myocardium but not in coronary vessels.
Chilian WM; Harrison DG; Haws CW; Snyder WD; Marcus ML
Circ Res; 1986 Jan; 58(1):68-82. PubMed ID: 3002658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
